Rule out all differentials before initiating growth hormone treatment in short MELAS patients

Documenti analoghi

• Rule out all differentials before initiating growth hormone treatment in short MELAS patients
  di: Josef Finsterer
  Pubblicazione: (2023-03-01)
• An improvement of the safety profile of SARS‐CoV‐2 vaccines is desirable
  di: Josef Finsterer
  Pubblicazione: (2024-10-01)
• Before blaming SARS-CoV-2 infection or vaccination for acute peripheral artery occlusion, rule out differential causes
  di: Josef Finsterer, et al.
  Pubblicazione: (2023-09-01)
• Before diagnosing SARS-CoV-2 vaccination-associated polyradiculitis, alternative explanations must be ruled out
  di: Ana Claudia Fiorini, et al.
  Pubblicazione: (2024-01-01)
• If SARS-CoV-2 vaccination is blamed for Parsonage–Turner syndrome, neurosurgical neurolysis is not indicated
  di: Fulvio A Scorza, et al.
  Pubblicazione: (2024-05-01)